Juan Solivera (Juan Solivera-Vela)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Neuroendocrine Tumors

Severe Traumatic Brain Injury

Hyaluronic Acid

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Jesús David Urbano-Gámez, Cinzia Guzzi, Manuel Bernal, Juan Solivera, Iñigo Martínez-Zubiaurre, Carlos Caro, María Luisa García-Martín
Tumor versus Tumor Cell Targeting in Metal-Based Nanoparticles for Cancer Theranostics. International journal of molecular sciences 25 (10) (2024)
Jesús David Urbano-Gámez, Cinzia Guzzi, Manuel Bernal, Juan Solivera, Iñigo Martínez-Zubiaurre, Carlos Caro, María Luisa García-Martín
Tumor versus Tumor Cell Targeting in Metal-Based Nanoparticles for Cancer Theranostics. International journal of molecular sciences 25 (10) (2024)
Cristóbal Blanco-Acevedo, Eduardo Agüera, Antonio C Fuentes-Fayos, Nazareth Pelaez-Viña, Rosa Diaz-Pernalete, Nazaret Infante-Santos, Ana Muñoz-Jurado, Manuel F Porras-Pantojo, Alejandro Ibáñez-Costa, Raul Miguel Luque, Juan Solivera
Decompressive Hemicraniectomy without Evacuation of Acute Intraparenchymal Hemorrhage. Biomedicines 12 (8) (2024)
Cristóbal Blanco-Acevedo, Eduardo Agüera, Antonio C Fuentes-Fayos, Nazareth Pelaez-Viña, Rosa Diaz-Pernalete, Nazaret Infante-Santos, Ana Muñoz-Jurado, Manuel F Porras-Pantojo, Alejandro Ibáñez-Costa, Raul Miguel Luque, Juan Solivera
Decompressive Hemicraniectomy without Evacuation of Acute Intraparenchymal Hemorrhage. Biomedicines 12 (8) (2024)
Antonio C Fuentes-Fayos, Miguel E G-García, Jesús M Pérez-Gómez, Annabel Peel, Cristóbal Blanco-Acevedo, Juan Solivera, Alejandro Ibáñez-Costa, Manuel D Gahete, Justo P. Castaño, Raul Miguel Luque
Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance. International journal of molecular sciences 23 (3) (2022)